PROTHENA CORPORATION PUBLIC LIMITED COMPANY Increase (Decrease) in Restructuring Reserve
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Increase (Decrease) in Restructuring Reserve of -$6.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestructuringReserve · last filed 2026-08-06
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in restructuring reserve for the quarter ending 2026-06-30 was -$6.49M, a 121.41% decline year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in restructuring reserve for the quarter ending 2026-03-31 was $480.00K.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in restructuring reserve for the quarter ending 2025-12-31 was -$4.31M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in restructuring reserve for the quarter ending 2025-09-30 was -$12.72M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in restructuring reserve for fiscal 2025 was $13.30M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in restructuring reserve for fiscal 2024 was $0.00.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in restructuring reserve for fiscal 2023 was $0.00.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY increase (decrease) in restructuring reserve for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Restructuring Reserve 3 month | Increase (Decrease) in Restructuring Reserve 6 month | Increase (Decrease) in Restructuring Reserve 9 month | Increase (Decrease) in Restructuring Reserve 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$6.01M 10-Q · filed 2026-08-06 | -$10.32M derived: sum of 3 quarters · filed 2026-08-06 | -$23.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $480.00K 10-Q · filed 2026-05-07 | -$3.83M derived: sum of 2 quarters · filed 2026-05-07 | -$16.55M derived: sum of 3 quarters · filed 2026-05-07 | $13.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$17.03M derived: sum of 2 quarters · filed 2026-02-27 | $13.30M derived: sum of 3 quarters · filed 2026-08-06 | $13.30M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$12.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $17.61M derived: sum of 2 quarters · filed 2026-08-06 | $17.61M 10-Q · filed 2025-11-06 | $17.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $30.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $30.33M 10-Q · filed 2026-08-06 | $30.33M derived: sum of 3 quarters · filed 2026-08-06 | $30.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-04 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-02-25 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | $0.00 10-Q · filed 2020-11-04 | $0.00 derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | -$461.00K 10-K · filed 2022-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | -$461.00K 10-Q · filed 2020-11-04 | -$4.34M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$461.00K 10-Q · filed 2020-08-06 | -$4.34M derived: sum of 3 quarters · filed 2021-02-26 | -$15.88M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$461.00K 10-Q · filed 2020-05-06 | -$4.34M derived: sum of 2 quarters · filed 2021-02-26 | -$15.88M derived: sum of 3 quarters · filed 2021-02-26 | $0.00 derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$15.42M derived: sum of 2 quarters · filed 2021-02-26 | $461.00K derived: sum of 3 quarters · filed 2021-02-26 | $461.00K 10-K · filed 2021-02-26 |
| 2018-09-30 | -$11.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $4.34M derived: sum of 2 quarters · filed 2019-11-05 | $4.34M 10-Q · filed 2019-11-05 | $4.34M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | $15.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $15.88M 10-Q · filed 2019-08-06 | $15.88M derived: sum of 3 quarters · filed 2020-03-03 | $15.88M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2020-03-03 | $0.00 derived: sum of 3 quarters · filed 2020-03-03 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $0.00 derived: sum of 2 quarters · filed 2020-03-03 | $0.00 10-K · filed 2020-03-03 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |